ArticleOncogene2022
Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
Patience Odeniyide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncogene2022
Patience Odeniyide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.